PNC Financial Services Group
OSIR

PNC Financial Services Group’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

PNC Financial Services Group’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-198
Closed -$1K – 4674
2016
Q2 		$1K Sell
198
-807
-80% -$4.34K ﹤0.01% 4477
2016
Q1 		$5K Buy
1,005
+205
+26% +$1.43K ﹤0.01% 3889
2015
Q4 		$8K Hold
800
– – ﹤0.01% 3717
2015
Q3 		$14K Hold
800
– – ﹤0.01% 3559
2015
Q2 		$16K Hold
800
– – ﹤0.01% 3614
2015
Q1 		$14K Buy
+800
New +$13.4K ﹤0.01% 3673

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PNC Financial Services Group's OSIR Position: Q3 2016 in Review

PNC Financial Services Group sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q3 2016, closing a stake of 198 shares — an estimated $1K sold.

PNC Financial Services Group first reported a position in OSIR in Q1 2015 and held it in 6 quarters. The position peaked at $16K in Q2 2015. 63 funds tracked by Wall St. Rank hold OSIR as of Q3 2016.

  • PNC Financial Services Group reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • PNC Financial Services Group sold 198 Osiris Therapeutics, Inc. Common Stock shares in Q3 2016, an estimated $1K.
  • PNC Financial Services Group first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2015 and held it in 6 quarters.
  • PNC Financial Services Group's Osiris Therapeutics, Inc. Common Stock position peaked at $16K in Q2 2015.
  • 63 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q3 2016.

Based on PNC Financial Services Group's 13F filing for Q3 2016, filed 4 Nov 2016.